Cubist Systematic Strategies’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Cubist Systematic Strategies’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,231	Closed	-$37K	–	3720
2021 Q3	$37K	Buy	12,231 +348	+3%	+$1.24K	﹤0.01%	2858
2021 Q2	$46K	Sell	11,883 -4,412	-27%	-$18.3K	﹤0.01%	2798
2021 Q1	$83K	Buy	+16,295	New	+$84.5K	﹤0.01%	2677
2019 Q1	–	Sell	-1,115	Closed	-$3K	–	2472
2018 Q4	$3K	Buy	+1,115	New	+$6.53K	﹤0.01%	2008
2018 Q3	–	Sell	-2,710	Closed	-$10K	–	2155
2018 Q2	$10K	Buy	+2,710	New	+$12.5K	﹤0.01%	1724

Other funds holding AGTC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cubist Systematic Strategies's AGTC Position: Q4 2021 in Review

Cubist Systematic Strategies sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2021, closing a stake of 12,231 shares — an estimated $37K sold.

Cubist Systematic Strategies first reported a position in AGTC in Q2 2018 and held it in 5 quarters. The position peaked at $83K in Q1 2021. 55 funds tracked by Wall St. Rank hold AGTC as of Q4 2021.

Cubist Systematic Strategies reported no remaining Applied Genetic Technologies Corporation position as of Q4 2021 after selling out during the quarter.
Cubist Systematic Strategies sold 12,231 Applied Genetic Technologies Corporation shares in Q4 2021, an estimated $37K.
Cubist Systematic Strategies first reported a position in Applied Genetic Technologies Corporation in Q2 2018 and held it in 5 quarters.
Cubist Systematic Strategies's Applied Genetic Technologies Corporation position peaked at $83K in Q1 2021.
55 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2021.

Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.